Dermsquared Scheduled Maintenance, Thursday Feb 29, 6:30am to 8:30am EST

Live Evaluations

A Clinicians Guide to Managing Hidradenitis Suppurativa: An In-Depth Workshop

About

A Clinicians Guide to Managing Hidradenitis Suppurativa: An In-Depth Workshop

This activity is supported by unrestricted educational grants from Incyte, Novartis Pharmaceutical Corporation and UCB, Inc.

Learning Objectives

At the completion of this activity, participants should be better able to:

  • Describe the pathways for the development of HS

  • Review emerging procedural and medical management of HS and strategies for incorporating into patient care

  • Discuss best practices in managing pain and wound care in HS

  • Develop strategies to involve patients in shared decision making

Intended Audience
This activity has been designed for dermatologists, dermatology physician assistants, dermatology nurse practitioners, and other providers involved in the care of patients.
Faculty
Noah
Noah Goldfarb, MD

Assistant Professor of Dermatology

University of Minnesota

Minneapolis, MN

Joslyn
Joslyn Kirby, MD

Associate Professor of Dermatology
Penn State Health
Hershey, PA

Hadar
Hadar Lev-Tov, MD

Associate Professor of Dermatology

University of Miami

Miami, FL

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement

The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 1.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures & Disclaimers

CONFLICTS OF INTEREST/DISCLOSURES

In accordance with the ACCME Standards for Commercial Support, balance, independence, objectivity, and scientific rigor are ensured in all CME activities. This requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with any ineligible companies. In addition, the content of this material has been approved by an independent peer reviewer. 

Disclosures are as follows:

Noah Goldfarb, MD

Advisory Board: Novartis, Boehringer Ingelheim and Sonoma Biotherapeutics

Grant/Research Support: Novartis and DeepX Health, HS Foundation and VA Funding

Consultant: Novartis, Boehringer Ingelheim and Sonoma Biotherapeutics

Intellectual Property Rights: Co-creator of HASI-R 

Joslyn R. Kirby, MD

Grant/Research Support: Incyte

Consultant: AbbVie,  Alumis, DermTech, Insmed, Incyte, Janssen

Speakers’ Bureau or Honoraria: AbbVie, Novartis, UCB, Janssen

Hadar Lev-Tov, MD

Advisory Board: Incyte

Grant/Research Support: Vomaris, NextScience Essity, Sigvaris

Consultant: Insmed, Novartis, UCB, Molnlycke

Ownership Interest (publicly traded): Learnskin

The planners have disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.  

The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.


Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved